Ro
PrivateLast Round
Series D
Extension
Feb 15, 2022
Est. Valuation
$7B
Total Funding Raised
$1.03B
Company Overview
Ro is a telehealth company offering a direct-to-consumer platform that facilitates diagnosis and convenient medication delivery, specializing in services for erectile dysfunction and smoking cessation with personalized treatment options.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Pharma Supply Chain, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ro Comps
Public and private peers based on sector, stage, and business model.
Ro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Feb 15, 2022 | ||||
| Series D | Mar 23, 2021 | ||||
| Series C | Jul 27, 2020 | ||||
| Series B | Apr 16, 2019 | ||||
| Series A | Sep 18, 2018 | ||||
Seed | Nov 6, 2017 |
Key People
Founding team and executive leadership
Ro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Torch Capital | Series D, Series A, Series C |
| Slow Ventures | Seed, Series A, Series B |
| 776 Capital | Series D |
| FirstMark Capital | Series D Extension, Series C, Series D, Series A, Series B |
| The Radcliff Companies | Series D |
| Dragoneer Investment Group | Series D |
| The Chernin Group | Series D Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Partnered with Eli Lilly to launch Zepbound KwikPen nationwide.
- Apr 2, 2026
Launched the FDA-approved Zepbound KwikPen nationwide.
Ro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ro's valuation, stock price, and market status.
